Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen Water Improves Blood Protein Health in Dialysis Patients

Improvement of the fraction of human mercaptalbumin on hemodialysis treatment using hydrogen-dissolved hemodialysis fluid: a prospective observational study

Research hubs: Cardiovascular System

Scientific visualization of hydrogen therapy research for Improvement of the fraction of human mercaptalbumin on hemodialysis treatment using hydrogen-dissolved hemodialysis fluid: a prospective observational study
Evidence type
Observational study · Human study
Authors
Kenji Maeda, Shigehito Yoshizaki, Toshiro Iida, Tomoyoshi Terada, Seiichi Era, Keiichiro Sakashita, Hajime Arikawa
Journal
Renal Replacement Therapy
Year
2016
Study Type
Human
Participants
74
Delivery
Solution (Dissolved)
Dose
Hydrogen-dissolved hemodialysis fluid via EW-C81-HD for 6 months
Duration
6 months
Outcome
Positive
Peer Reviewed
Yes
Cited by
12 (OpenAlex, as of November 2026)
Country
Japan

TL;DR

Using hydrogen-enriched water for long-term hemodialysis treatment may improve the antioxidant status of patients' blood.

Key Finding

Patients treated with hydrogen-dissolved hemodialysis fluid for 6 months showed a significant increase in protective albumin levels, rising from 51% to 58% before dialysis and from 72% to 76% after dialysis, approaching the 79% levels seen in healthy subjects.

Summary

This study tested whether hemodialysis fluid containing dissolved hydrogen could improve a marker of oxidative stress (cellular damage from unstable molecules) in kidney dialysis patients. Twelve patients received hydrogen-enriched dialysis fluid for 6 months, and researchers measured a specific form of albumin (a blood protein) that indicates protection against oxidative stress. After 6 months, this protective form of albumin increased significantly in the hydrogen-treated group, approaching levels seen in healthy people.

Practical Takeaway

This small human study suggests that hydrogen-enriched dialysis fluid may help reduce oxidative stress markers in kidney dialysis patients over 6 months. However, the study included only 12 patients and did not measure whether this improvement actually reduces heart disease risk or improves patient outcomes—only that a specific blood marker improved. More research is needed to determine if these changes translate to real health benefits.

Abstract (excerpt)

Background Oxidative stress (OS) is said to increase in hemodialysis therapy, so that the electrolyzed water-hemodialysis (EW-HD) dissolving hydrogen in hemodialysis fluid has been tried for the reduction of OS. It is reported that the risk of cardiovascular disease events increased if the fraction…

Read the full abstract via DOI